An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has removed violative content and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service safe and investing in enhancing compliance measures.
Digital Marketplace Activities
Research also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
After minutes of entering one group, a seller posted contact information, where the majority of transactions occur. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Item Information and Costs
Within these groups, messages show dark colored packages with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for the messaging service said it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject patients to potentially significant health risks”.
